Markéta Hlaváčková

660 total citations
39 papers, 455 citations indexed

About

Markéta Hlaváčková is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Markéta Hlaváčková has authored 39 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Physiology. Recurrent topics in Markéta Hlaváčková's work include RNA modifications and cancer (9 papers), Mitochondrial Function and Pathology (8 papers) and Cardiac Ischemia and Reperfusion (8 papers). Markéta Hlaváčková is often cited by papers focused on RNA modifications and cancer (9 papers), Mitochondrial Function and Pathology (8 papers) and Cardiac Ischemia and Reperfusion (8 papers). Markéta Hlaváčková collaborates with scholars based in Czechia, United States and Netherlands. Markéta Hlaváčková's co-authors include František Kolář, Jan Neckář, Olga Nováková, Gudrun H. Borchert, František Novák, Marie Milerová, Dalibor Šatı́nský, Petr Solich, I Ošťádalová and B Ošťádal and has published in prestigious journals such as Journal of Biological Chemistry, Food Chemistry and Journal of Applied Physiology.

In The Last Decade

Markéta Hlaváčková

37 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markéta Hlaváčková Czechia 15 266 107 95 86 84 39 455
Renee Wong United States 14 351 1.3× 148 1.4× 153 1.6× 109 1.3× 43 0.5× 20 623
Viktor Pastukh United States 13 387 1.5× 75 0.7× 55 0.6× 127 1.5× 57 0.7× 25 637
Brian Siu Hong Kong 6 243 0.9× 163 1.5× 83 0.9× 109 1.3× 21 0.3× 17 512
Miroslav Ferko Slovakia 14 268 1.0× 155 1.4× 115 1.2× 85 1.0× 58 0.7× 38 521
Hitesh Soni United States 15 244 0.9× 91 0.9× 65 0.7× 56 0.7× 26 0.3× 35 538
Rowena Kemp United States 12 247 0.9× 94 0.9× 68 0.7× 102 1.2× 40 0.5× 15 599
Andrew J. Tompkins United States 7 400 1.5× 205 1.9× 48 0.5× 184 2.1× 44 0.5× 11 632
Honghua Qin United States 5 149 0.6× 94 0.9× 75 0.8× 116 1.3× 18 0.2× 6 412
Munish Kumar United States 12 210 0.8× 58 0.5× 73 0.8× 104 1.2× 65 0.8× 23 628
A R Hall United Kingdom 4 341 1.3× 99 0.9× 67 0.7× 81 0.9× 25 0.3× 9 472

Countries citing papers authored by Markéta Hlaváčková

Since Specialization
Citations

This map shows the geographic impact of Markéta Hlaváčková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markéta Hlaváčková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markéta Hlaváčková more than expected).

Fields of papers citing papers by Markéta Hlaváčková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markéta Hlaváčková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markéta Hlaváčková. The network helps show where Markéta Hlaváčková may publish in the future.

Co-authorship network of co-authors of Markéta Hlaváčková

This figure shows the co-authorship network connecting the top 25 collaborators of Markéta Hlaváčková. A scholar is included among the top collaborators of Markéta Hlaváčková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markéta Hlaváčková. Markéta Hlaváčková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolář, František, et al.. (2025). Epitranscriptomic regulation of HIF-1: bidirectional regulatory pathways. Molecular Medicine. 31(1). 105–105. 7 indexed citations
2.
Hlaváčková, Markéta, et al.. (2025). Epitranscriptomic signatures in blood: emerging biomarkers for diagnosis of diabetes and its complications. Frontiers in Cell and Developmental Biology. 13. 1656769–1656769.
3.
Hlaváčková, Markéta, et al.. (2024). Epitranscriptomic regulations in the heart. Physiological Research. 73(Suppl 1). S185–S198. 3 indexed citations
4.
Hlaváčková, Markéta, et al.. (2024). FTO in health and disease. Frontiers in Cell and Developmental Biology. 12. 1500394–1500394. 7 indexed citations
5.
Kolář, František, et al.. (2024). Unveiling the proteome of the fasting heart: Insights into HIF-1 pathway regulation. Frontiers in Physiology. 15. 1462014–1462014. 2 indexed citations
6.
Pecina, Petr, Vilma Kaplanová, Jan Šilhavý, et al.. (2024). Haplotype variability in mitochondrial rRNA predisposes to metabolic syndrome. Communications Biology. 7(1). 1116–1116. 2 indexed citations
7.
Kolář, František, et al.. (2023). Developmental Aspects of Cardiac Adaptation to Increased Workload. Journal of Cardiovascular Development and Disease. 10(5). 205–205. 5 indexed citations
8.
Kolář, František, et al.. (2023). RNA modification m 6 Am: the role in cardiac biology. Epigenetics. 18(1). 2218771–2218771. 19 indexed citations
9.
Plecitá‐Hlavatá, Lydie, et al.. (2023). The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus. Frontiers in Endocrinology. 14. 1223583–1223583. 19 indexed citations
10.
Kolář, František, et al.. (2022). Myocardial epitranscriptomics in fasting. Journal of Molecular and Cellular Cardiology. 173. S52–S52. 1 indexed citations
11.
Jirkovský, Eduard, Markéta Hlaváčková, Hana Jansová, et al.. (2019). In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline. Clinical Science. 133(16). 1827–1844. 12 indexed citations
12.
Podolnikova, Nataly P., Markéta Hlaváčková, Valentin P. Yakubenko, et al.. (2019). Interaction between the integrin Mac-1 and signal regulatory protein α (SIRPα) mediates fusion in heterologous cells. Journal of Biological Chemistry. 294(19). 7833–7849. 20 indexed citations
13.
Neckář, Jan, et al.. (2019). Selection of optimal reference genes for gene expression studies in chronically hypoxic rat heart. Molecular and Cellular Biochemistry. 461(1-2). 15–22. 14 indexed citations
14.
Hlaváčková, Markéta, Elissavet Kardami, Robert R. Fandrich, & Grant N. Pierce. (2018). Do different nuclei in a binucleated cardiomyocyte have different rates of nuclear protein import?. Journal of Molecular and Cellular Cardiology. 126. 140–142. 1 indexed citations
15.
Deniset, Justin, Markéta Hlaváčková, Mirna N. Chahine, et al.. (2018). Heat shock protein 60 involvement in vascular smooth muscle cell proliferation. Cellular Signalling. 47. 44–51. 17 indexed citations
16.
Eckhardt, Adam, Ivan Mikšı́k, Statis Pataridis, et al.. (2018). Proteomic analysis of cardiac ventricles: baso-apical differences. Molecular and Cellular Biochemistry. 445(1-2). 211–219. 6 indexed citations
17.
Hlaváčková, Markéta, Jitka Žurmanová, Gudrun H. Borchert, et al.. (2015). Involvement of PKCε in Cardioprotection Induced by Adaptation to Chronic Continuous Hypoxia. Physiological Research. 64(2). 191–201. 13 indexed citations
18.
Hlaváčková, Markéta, et al.. (2013). A rapid HPLC column switching method for sample preparation and determination of β-carotene in food supplements. Food Chemistry. 141(2). 1433–1437. 27 indexed citations
19.
Ježková, Jana, Markéta Hlaváčková, Jan Neckář, et al.. (2009). Dietary polyunsaturated fatty acids and adaptation to chronic hypoxia alter acyl composition of serum and heart lipids. British Journal Of Nutrition. 102(9). 1297–1307. 10 indexed citations
20.
Hlaváčková, Markéta, Jan Neckář, Jana Ježková, et al.. (2007). Dietary polyunsaturated fatty acids alter myocardial protein kinase C expression and affect cardioprotection induced by chronic hypoxia.. PubMed. 232(6). 823–32. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renee Wong Breakdown of academic impact, for papers by Viktor Pastukh Breakdown of academic impact, for papers by Brian Siu Breakdown of academic impact, for papers by Miroslav Ferko Breakdown of academic impact, for papers by Hitesh Soni Breakdown of academic impact, for papers by Rowena Kemp Breakdown of academic impact, for papers by Andrew J. Tompkins Breakdown of academic impact, for papers by Honghua Qin Breakdown of academic impact, for papers by Munish Kumar Breakdown of academic impact, for papers by A R Hall
Rankless by CCL
2026